These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis. Sherlock S Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193 [TBL] [Abstract][Full Text] [Related]
27. Current understanding of primary biliary cholangitis. Tanaka A Clin Mol Hepatol; 2021 Jan; 27(1):1-21. PubMed ID: 33264835 [TBL] [Abstract][Full Text] [Related]
28. Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms. Bombaci M; Pesce E; Torri A; Carpi D; Crosti M; Lanzafame M; Cordiglieri C; Sinisi A; Moro M; Bernuzzi F; Gerussi A; Geginat J; Muratori L; Terracciano LM; Invernizzi P; Abrignani S; Grifantini R Liver Int; 2019 Nov; 39(11):2124-2135. PubMed ID: 31033124 [TBL] [Abstract][Full Text] [Related]
29. Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature. Weyman RL; Voigt M Am J Gastroenterol; 2001 Feb; 96(2):585-7. PubMed ID: 11232713 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS). Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146 [TBL] [Abstract][Full Text] [Related]
31. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416 [TBL] [Abstract][Full Text] [Related]
32. [Pruritus in liver disease: case report with discussion]. Hug B; Fried R; Terracciano L Praxis (Bern 1994); 1998 Dec; 87(51-52):1805-10. PubMed ID: 10025154 [TBL] [Abstract][Full Text] [Related]
33. Primary biliary cirrhosis. Moreno-Otero R; Lisker-Melman M; Jones EA Med Clin North Am; 1989 Jul; 73(4):911-29. PubMed ID: 2657267 [TBL] [Abstract][Full Text] [Related]
35. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656 [TBL] [Abstract][Full Text] [Related]
36. Clinical significance of autoantibodies in primary biliary cirrhosis. Nakamura M Semin Liver Dis; 2014 Aug; 34(3):334-40. PubMed ID: 25057956 [TBL] [Abstract][Full Text] [Related]
37. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Heathcote EJ Hepatology; 2000 Apr; 31(4):1005-13. PubMed ID: 10733559 [TBL] [Abstract][Full Text] [Related]
38. Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: A single-center study. Guatibonza-García V; Gaete PV; Pérez-Londoño A; Puerto-Baracaldo DK; Gutiérrez-Romero SA; Mendivil CO; Tapias M World J Gastroenterol; 2021 Aug; 27(29):4890-4899. PubMed ID: 34447233 [TBL] [Abstract][Full Text] [Related]
39. Etiology of primary biliary cirrhosis: the search for the culprit. Leung PS; Coppel RL; Gershwin ME Semin Liver Dis; 2005 Aug; 25(3):327-36. PubMed ID: 16143948 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Liberal R; Grant CR; Sakkas L; Bizzaro N; Bogdanos DP Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):572-85. PubMed ID: 23876351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]